Technical Analysis for XGN - Exagen Inc.

Grade Last Price % Change Price Change
grade F 17.82 -3.05% -0.56
XGN closed down 3.05 percent on Friday, February 21, 2020, on 85 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical XGN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Wide Bands Range Expansion -3.05%
Down 3 Days in a Row Weakness -3.05%
Multiple of Ten Bearish Other -7.19%
Wide Bands Range Expansion -7.19%
20 DMA Resistance Bearish -7.28%
180 Bearish Setup Bearish Swing Setup -7.28%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.28%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Exagen Inc. operates as a commercial-stage diagnostics company, develops and markets products for the diagnosis, prognosis, and monitoring of patients affected by autoimmune rheumatic diseases (ARDs). Its lead product includes Avise SLE+CT, a proprietary diagnostic test that provides an enhanced solution for patients with a range of ARDs, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren's syndrome, and scleroderma, as well as other disorders, including fibromyalgia. The company also offers Avise SLE Prognostic, a blood test that complements Avise SLE+CT; Avise MTX, a therapeutic drug monitoring test to measure levels of methotrexate polyglutamates; and Avise HCQ, a blood test for physicians to monitor blood levels of HCQ. In addition, it is developing Anti-TNF, a blood test to monitor the levels of anti-TNF bioactivity in patients with RA; Avise SLE Monitoring, a multi-analyte panel blood test for physicians to track the disease status of their SLE patients; and Avise RA, a blood test to determine bone damage or joint erosion. The company primarily serves rheumatologists in the United States. It was formerly known as Exagen Diagnostics, Inc. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
Medicine Medical Specialties Clinical Medicine Immunology Disease Autoimmune Diseases Disorders Rheumatoid Arthritis Autoimmunity Rheumatology Fibromyalgia Scleroderma Sjögren's Syndrome Sle Systemic Lupus Erythematosus

Is XGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 29.858
52 Week Low 11.54
Average Volume 82,545
200-Day Moving Average 0.00
50-Day Moving Average 22.02
20-Day Moving Average 20.35
10-Day Moving Average 18.87
Average True Range 1.84
ADX 19.2
+DI 13.84
-DI 19.68
Chandelier Exit (Long, 3 ATRs ) 19.46
Chandelier Exit (Short, 3 ATRs ) 22.57
Upper Bollinger Band 24.06
Lower Bollinger Band 16.63
Percent B (%b) 0.16
BandWidth 36.50
MACD Line -1.08
MACD Signal Line -0.92
MACD Histogram -0.1592
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.95
Resistance 3 (R3) 19.93 19.20 19.60
Resistance 2 (R2) 19.20 18.66 19.21 19.48
Resistance 1 (R1) 18.51 18.32 18.15 18.53 19.36
Pivot Point 17.78 17.78 17.60 17.79 17.78
Support 1 (S1) 17.09 17.24 16.73 17.11 16.28
Support 2 (S2) 16.36 16.90 16.37 16.16
Support 3 (S3) 15.67 16.36 16.05
Support 4 (S4) 15.69